This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Brookdale to Recruit More People Amid the Coronavirus Crisis
by Sapna Bagaria
Brookdale (BKD) decides to hire additional forces to serve senior living communities more efficiently during the coronavirus pandemic.
4 Telehealth Stocks Amid Coronavirus-Led Lockdown
by Zacks Equity Research
Telemedicine has emerged as the need of the hour for homebound Americans seeking medical expertise because of the pandemic.
Centene Soars 47.8% in Six Months: Will the Rally Continue?
by Zacks Equity Research
Centene's (CNC) strategic initiatives and higher membership might aid its revenues to perk up its share price in turn.
Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks
by Tirthankar Chakraborty
Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.
Top Stock Reports for Facebook, JPMorgan & UnitedHealth
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), JPMorgan Chase (JPM) and UnitedHealth Group (UNH).
UnitedHealth to Offer Financial Aid to Healthcare Providers
by Zacks Equity Research
UnitedHealth (UNH) has extended financial support to its healthcare providers in the United States, who are constantly making efforts to contain the coronavirus spread.
Why Humana (HUM) Stock Might be a Great Pick
by Zacks Equity Research
Humana (HUM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well
Why the Earnings Surprise Streak Could Continue for Humana (HUM)
by Zacks Equity Research
Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Anthem to Remove Costs Related to Coronavirus Treatment
by Zacks Equity Research
Anthem's (ANTM) decision to eliminate supplementary costs related to the coronavirus treatment bodes well for its members.
Humana to Waive Expenses Related to Coronavirus Treatment
by Zacks Equity Research
Humana (HUM) to excuse members' out-of-pocket costs for COVID-19 treatment.
Cigna (CI) Ramps up Efforts to Contain Coronavirus Spread
by Zacks Equity Research
Cigna (CI) actively expands service suite for customers, thereby, helping contain the virus spread.
SEM vs. HUM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SEM vs. HUM: Which Stock Is the Better Value Option?
eBay, Cinemark, Teladoc, UnitedHealth and Humana as Zacks Bull and Bear of the Day
by Zacks Equity Research
eBay, Cinemark, Teladoc, UnitedHealth and Humana as Zacks Bull and Bear of the Day
UnitedHealth Offers Relief to Clients in Houston Amid Crisis
by Zacks Equity Research
UnitedHealth (UNH) expands its contract with Methodist to provide its members access to the hospital's doctors amid the global crisis.
Teladoc (TDOC) Up 90% Year to Date: Will the Rally Continue?
by Zacks Equity Research
Teladoc (TDOC) benefits from a surge in telehealth services due to COVID-19 outbreak.
UnitedHealth's Unit Expands Services Amid Coronavirus Outbreak
by Sapna Bagaria
UnitedHealth's (UNH) UnitedHealthcare business actively enhances service suites for customers, thereby helping contain the virus spread.
Humana (HUM) Extends Telehealth Services to Fight Coronavirus
by Zacks Equity Research
Humana (HUM) enhances its telehealth service facilities to combat the spread of COVID-19.
Magellan Health's Unit Enhances Services to Fight Coronavirus
by Zacks Equity Research
Magellan Health's (MGLN) behavioral and specialty healthcare segment betters its behavorial health services for those in emergency to contain the COVID-19 spread.
Top Stock Reports for Toyota, Comcast & S&P Global
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Toyota Motor (TM), Comcast (CMCSA) and S&P Global (SPGI).
Humana (HUM) Continues to Ride on Medicare Business Momentum
by Zacks Equity Research
Humana (HUM) consistently thrives on the back of its well-performing Medicare business.
Humana (HUM) Up 3.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Centene (CNC) Reduces 2020 Earnings Estimates, Shares Slide
by Zacks Equity Research
Centene (CNC) updates its 2020 outlook that reflects its WellCare buyout and the potential Medicaid rate decrease.
Tenet Healthcare Rides on Inorganic Growth, Reduces Leverage
by Zacks Equity Research
Tenet Healthcare (THC) gains traction from strategic initiatives and declining debt load.
Humana Extends Value-based Care Services in North Carolina
by Zacks Equity Research
Humana (HUM) strengthens ties with Aledade to expand value-based care services for its Medicare Advantage members in North Carolina.
Will UnitedHealth Stock Witness Volatility til the Elections?
by Sapna Bagaria
Shares of UnitedHealth (UNH) slide on Sanders' Nevada win. Volatility is likely to continue till the elections.